Lung Cancer Home > Mechlorethamine Chemotherapy Information
Mechlorethamine (Mustargen®) is a prescription medicine approved for the treatment of lung cancer and certain blood and bone marrow cancers. It is also licensed to help treat metastatic cancer associated with effusion. Metastatic cancer is cancer that has spread from its original site to other areas of the body. Effusion occurs when excess fluid builds up in the space between membranes that line body organs, such as the lungs or abdomen (stomach).
This medication is usually given as an injection into a vein (an intravenous, or IV, injection), although it may also be given directly into body cavities (the lining of the lungs, heart, or abdomen).
Before beginning chemotherapy treatment with mechlorethamine, make sure to review the safety information with your healthcare provider. For example, you may not be able to use this medicine if you have an infection, gout, or certain other medical conditions. Also, this drug may react with a few other medications.
(For more information on this chemotherapy drug, click Mechlorethamine. This article takes a closer look, including details on how it works, dosing guidelines, and possible side effects.)